#Russia’s Cancer Vaccine rolls out amidst Geopolitical Storms!

A new mRNA-based vaccine, Enteromix, completes preclinical trials with reported success, aiming to revolutionize cancer treatment.

0 2 minutes read

#Russia’s Cancer Vaccine rolls out amidst Geopolitical Storms! In a significant development for global oncology, Russia has announced that its new cancer vaccine, “Enteromix,” has successfully completed preclinical trials and is now ready for clinical use.

The announcement was made by Veronika Skvortsova, head of the Federal Medical and Biological Agency (FMBA), at the Eastern Economic Forum. According to reports, the vaccine has shown remarkable efficacy and safety, with preclinical studies indicating a significant reduction in tumor size and progression, as well as improved survival rates.

This groundbreaking vaccine leverages mRNA technology, similar to that used in some COVID-19 vaccines, to train the body’s own immune system to identify and attack cancer cells

Unlike traditional treatments like chemotherapy, which often come with severe side effects, Enteromix is designed to be a more targeted and less harsh therapy.

The vaccine is also reportedly personalized, with a key feature being its customization to each patient’s individual RNA profile, creating a bespoke treatment for their specific

— BRICS News (@BRICSinfo) tweets on ‘X’ ! September 6, 2025

JUST IN: 🇷🇺 Russia officially announces cancer vaccine is ready for clinical use, rolled out to patients for free. pic.twitter.com/lxkdvJXW5D

— BRICS News (@BRICSinfo) September 6, 2025

The trials involved 48 volunteers and were conducted by Russia’s National Medical Research Radiology Centre in collaboration with the Engelhardt Institute of Molecular Biology. The announcement made at the 2025 Petersburg International Economic Forum, frames this Russian cancer vaccine as the potential game changer in oncology.

— RussiaNews 🇷🇺 (@mog_russEN) Tweets on ‘X’ ! September 7, 2025

http://

🚨⚡️ JUST IN:

Russia unveils a REVOLUTIONARY cancer vaccine now ready for clinical use — FREE for patients.

FMBA chief Skvortsova: “3 years of trials PROVED safety & high efficacy.” pic.twitter.com/jQkO8dcMNi

— RussiaNews 🇷🇺 (@mog_russEN) September 7, 2025

The initial version of the vaccine is aimed at treating colorectal cancer, a leading cause of cancer-related deaths worldwide. Furthermore, researchers are making promising progress on developing versions for other aggressive cancers, including glioblastoma, a type of brain tumor, and specific forms of melanoma.

— Tech Ranjan Crypto (@TRanjanofficial) Tweets on ‘X’ ! September 8, 2025

http://

🎉Exciting news from Russia🎉

A new mRNA-based cancer vaccine has shown remarkable results in trials, with 100% efficacy and safety. approved, it will be available free to all patients, marking a groundbreaking step forward in cancer treatment! 🌍💉

#CancerVaccine… pic.twitter.com/06At860vPc

— Tech Ranjan Crypto (@TRanjanofficial) September 8, 2025

The state has indicated that the vaccine will be provided to Russian citizens free of charge, with the government covering the estimated production cost per dose. While the scientific community remains cautiously optimistic, this development marks a potential turning point in the fight against one of the world’s most formidable diseases.

Indian context :

Ongoing research: India has a high cancer burden, and new treatments like mRNA vaccines could be very impactful. The development of new therapies is a major priority for the country’s healthcare system.

Skepticism and caution: As with any new breakthrough, India’s medical community is monitoring the situation with a mix of interest and caution, waiting for verifiable, peer-reviewed data before accepting the findings as definitive.

Source: https://eimb.ru

https://new.nmicr.ru

http://x.com

Catch up for more on : http://indiainput.com